Global Alzheimer's Disease Diagnostic Market Research Report 2022
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alzheimer's Disease Diagnostic Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Nervous System Examination
1.2.3 Genetic Testing
1.2.4 Minor Mental State Examination (Mmse)
1.2.5 Brain Imaging
1.3 Market by Application
1.3.1 Global Alzheimer's Disease Diagnostic Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Early-Onset Alzheimer's Disease
1.3.3 Familial Alzheimer's Disease
1.3.4 Late-Onset Alzheimer's Disease
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Alzheimer's Disease Diagnostic Market Perspective (2017-2028)
2.2 Alzheimer's Disease Diagnostic Growth Trends by Region
2.2.1 Alzheimer's Disease Diagnostic Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Alzheimer's Disease Diagnostic Historic Market Size by Region (2017-2022)
2.2.3 Alzheimer's Disease Diagnostic Forecasted Market Size by Region (2023-2028)
2.3 Alzheimer's Disease Diagnostic Market Dynamics
2.3.1 Alzheimer's Disease Diagnostic Industry Trends
2.3.2 Alzheimer's Disease Diagnostic Market Drivers
2.3.3 Alzheimer's Disease Diagnostic Market Challenges
2.3.4 Alzheimer's Disease Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alzheimer's Disease Diagnostic Players by Revenue
3.1.1 Global Top Alzheimer's Disease Diagnostic Players by Revenue (2017-2022)
3.1.2 Global Alzheimer's Disease Diagnostic Revenue Market Share by Players (2017-2022)
3.2 Global Alzheimer's Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Alzheimer's Disease Diagnostic Revenue
3.4 Global Alzheimer's Disease Diagnostic Market Concentration Ratio
3.4.1 Global Alzheimer's Disease Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alzheimer's Disease Diagnostic Revenue in 2021
3.5 Alzheimer's Disease Diagnostic Key Players Head office and Area Served
3.6 Key Players Alzheimer's Disease Diagnostic Product Solution and Service
3.7 Date of Enter into Alzheimer's Disease Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Alzheimer's Disease Diagnostic Breakdown Data by Type
4.1 Global Alzheimer's Disease Diagnostic Historic Market Size by Type (2017-2022)
4.2 Global Alzheimer's Disease Diagnostic Forecasted Market Size by Type (2023-2028)
5 Alzheimer's Disease Diagnostic Breakdown Data by Application
5.1 Global Alzheimer's Disease Diagnostic Historic Market Size by Application (2017-2022)
5.2 Global Alzheimer's Disease Diagnostic Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Alzheimer's Disease Diagnostic Market Size (2017-2028)
6.2 North America Alzheimer's Disease Diagnostic Market Size by Country (2017-2022)
6.3 North America Alzheimer's Disease Diagnostic Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Alzheimer's Disease Diagnostic Market Size (2017-2028)
7.2 Europe Alzheimer's Disease Diagnostic Market Size by Country (2017-2022)
7.3 Europe Alzheimer's Disease Diagnostic Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alzheimer's Disease Diagnostic Market Size (2017-2028)
8.2 Asia-Pacific Alzheimer's Disease Diagnostic Market Size by Country (2017-2022)
8.3 Asia-Pacific Alzheimer's Disease Diagnostic Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Alzheimer's Disease Diagnostic Market Size (2017-2028)
9.2 Latin America Alzheimer's Disease Diagnostic Market Size by Country (2017-2022)
9.3 Latin America Alzheimer's Disease Diagnostic Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alzheimer's Disease Diagnostic Market Size (2017-2028)
10.2 Middle East & Africa Alzheimer's Disease Diagnostic Market Size by Country (2017-2022)
10.3 Middle East & Africa Alzheimer's Disease Diagnostic Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Detail
11.1.2 Eli Lilly and Company Business Overview
11.1.3 Eli Lilly and Company Alzheimer's Disease Diagnostic Introduction
11.1.4 Eli Lilly and Company Revenue in Alzheimer's Disease Diagnostic Business (2017-2022)
11.1.5 Eli Lilly and Company Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Alzheimer's Disease Diagnostic Introduction
11.2.4 Novartis Revenue in Alzheimer's Disease Diagnostic Business (2017-2022)
11.2.5 Novartis Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Alzheimer's Disease Diagnostic Introduction
11.3.4 Merck Revenue in Alzheimer's Disease Diagnostic Business (2017-2022)
11.3.5 Merck Recent Development
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Detail
11.4.2 F. Hoffmann-La Roche Business Overview
11.4.3 F. Hoffmann-La Roche Alzheimer's Disease Diagnostic Introduction
11.4.4 F. Hoffmann-La Roche Revenue in Alzheimer's Disease Diagnostic Business (2017-2022)
11.4.5 F. Hoffmann-La Roche Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Alzheimer's Disease Diagnostic Introduction
11.5.4 Pfizer Revenue in Alzheimer's Disease Diagnostic Business (2017-2022)
11.5.5 Pfizer Recent Development
11.6 TauRx
11.6.1 TauRx Company Detail
11.6.2 TauRx Business Overview
11.6.3 TauRx Alzheimer's Disease Diagnostic Introduction
11.6.4 TauRx Revenue in Alzheimer's Disease Diagnostic Business (2017-2022)
11.6.5 TauRx Recent Development
11.7 Alector
11.7.1 Alector Company Detail
11.7.2 Alector Business Overview
11.7.3 Alector Alzheimer's Disease Diagnostic Introduction
11.7.4 Alector Revenue in Alzheimer's Disease Diagnostic Business (2017-2022)
11.7.5 Alector Recent Development
11.8 Accera
11.8.1 Accera Company Detail
11.8.2 Accera Business Overview
11.8.3 Accera Alzheimer's Disease Diagnostic Introduction
11.8.4 Accera Revenue in Alzheimer's Disease Diagnostic Business (2017-2022)
11.8.5 Accera Recent Development
11.9 Treventis Corporation
11.9.1 Treventis Corporation Company Detail
11.9.2 Treventis Corporation Business Overview
11.9.3 Treventis Corporation Alzheimer's Disease Diagnostic Introduction
11.9.4 Treventis Corporation Revenue in Alzheimer's Disease Diagnostic Business (2017-2022)
11.9.5 Treventis Corporation Recent Development
11.10 Neuro-Bio
11.10.1 Neuro-Bio Company Detail
11.10.2 Neuro-Bio Business Overview
11.10.3 Neuro-Bio Alzheimer's Disease Diagnostic Introduction
11.10.4 Neuro-Bio Revenue in Alzheimer's Disease Diagnostic Business (2017-2022)
11.10.5 Neuro-Bio Recent Development
11.11 Cognition Therapeutics
11.11.1 Cognition Therapeutics Company Detail
11.11.2 Cognition Therapeutics Business Overview
11.11.3 Cognition Therapeutics Alzheimer's Disease Diagnostic Introduction
11.11.4 Cognition Therapeutics Revenue in Alzheimer's Disease Diagnostic Business (2017-2022)
11.11.5 Cognition Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Alzheimer's Disease Diagnostic Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Nervous System Examination
Table 3. Key Players of Genetic Testing
Table 4. Key Players of Minor Mental State Examination (Mmse)
Table 5. Key Players of Brain Imaging
Table 6. Global Alzheimer's Disease Diagnostic Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Alzheimer's Disease Diagnostic Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Alzheimer's Disease Diagnostic Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Alzheimer's Disease Diagnostic Market Share by Region (2017-2022)
Table 10. Global Alzheimer's Disease Diagnostic Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Alzheimer's Disease Diagnostic Market Share by Region (2023-2028)
Table 12. Alzheimer's Disease Diagnostic Market Trends
Table 13. Alzheimer's Disease Diagnostic Market Drivers
Table 14. Alzheimer's Disease Diagnostic Market Challenges
Table 15. Alzheimer's Disease Diagnostic Market Restraints
Table 16. Global Alzheimer's Disease Diagnostic Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Alzheimer's Disease Diagnostic Market Share by Players (2017-2022)
Table 18. Global Top Alzheimer's Disease Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Diagnostic as of 2021)
Table 19. Ranking of Global Top Alzheimer's Disease Diagnostic Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Alzheimer's Disease Diagnostic Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Alzheimer's Disease Diagnostic Product Solution and Service
Table 23. Date of Enter into Alzheimer's Disease Diagnostic Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Alzheimer's Disease Diagnostic Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Alzheimer's Disease Diagnostic Revenue Market Share by Type (2017-2022)
Table 27. Global Alzheimer's Disease Diagnostic Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Alzheimer's Disease Diagnostic Revenue Market Share by Type (2023-2028)
Table 29. Global Alzheimer's Disease Diagnostic Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Alzheimer's Disease Diagnostic Revenue Market Share by Application (2017-2022)
Table 31. Global Alzheimer's Disease Diagnostic Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Alzheimer's Disease Diagnostic Revenue Market Share by Application (2023-2028)
Table 33. North America Alzheimer's Disease Diagnostic Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Alzheimer's Disease Diagnostic Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Alzheimer's Disease Diagnostic Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Alzheimer's Disease Diagnostic Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Alzheimer's Disease Diagnostic Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Alzheimer's Disease Diagnostic Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Alzheimer's Disease Diagnostic Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Alzheimer's Disease Diagnostic Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Alzheimer's Disease Diagnostic Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Alzheimer's Disease Diagnostic Market Size by Country (2023-2028) & (US$ Million)
Table 43. Eli Lilly and Company Company Detail
Table 44. Eli Lilly and Company Business Overview
Table 45. Eli Lilly and Company Alzheimer's Disease Diagnostic Product
Table 46. Eli Lilly and Company Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 47. Eli Lilly and Company Recent Development
Table 48. Novartis Company Detail
Table 49. Novartis Business Overview
Table 50. Novartis Alzheimer's Disease Diagnostic Product
Table 51. Novartis Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 52. Novartis Recent Development
Table 53. Merck Company Detail
Table 54. Merck Business Overview
Table 55. Merck Alzheimer's Disease Diagnostic Product
Table 56. Merck Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 57. Merck Recent Development
Table 58. F. Hoffmann-La Roche Company Detail
Table 59. F. Hoffmann-La Roche Business Overview
Table 60. F. Hoffmann-La Roche Alzheimer's Disease Diagnostic Product
Table 61. F. Hoffmann-La Roche Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 62. F. Hoffmann-La Roche Recent Development
Table 63. Pfizer Company Detail
Table 64. Pfizer Business Overview
Table 65. Pfizer Alzheimer's Disease Diagnostic Product
Table 66. Pfizer Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. TauRx Company Detail
Table 69. TauRx Business Overview
Table 70. TauRx Alzheimer's Disease Diagnostic Product
Table 71. TauRx Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 72. TauRx Recent Development
Table 73. Alector Company Detail
Table 74. Alector Business Overview
Table 75. Alector Alzheimer's Disease Diagnostic Product
Table 76. Alector Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 77. Alector Recent Development
Table 78. Accera Company Detail
Table 79. Accera Business Overview
Table 80. Accera Alzheimer's Disease Diagnostic Product
Table 81. Accera Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 82. Accera Recent Development
Table 83. Treventis Corporation Company Detail
Table 84. Treventis Corporation Business Overview
Table 85. Treventis Corporation Alzheimer's Disease Diagnostic Product
Table 86. Treventis Corporation Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 87. Treventis Corporation Recent Development
Table 88. Neuro-Bio Company Detail
Table 89. Neuro-Bio Business Overview
Table 90. Neuro-Bio Alzheimer's Disease Diagnostic Product
Table 91. Neuro-Bio Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 92. Neuro-Bio Recent Development
Table 93. Cognition Therapeutics Company Detail
Table 94. Cognition Therapeutics Business Overview
Table 95. Cognition Therapeutics Alzheimer's Disease DiagnosticProduct
Table 96. Cognition Therapeutics Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million)
Table 97. Cognition Therapeutics Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Alzheimer's Disease Diagnostic Market Share by Type: 2021 VS 2028
Figure 2. Nervous System Examination Features
Figure 3. Genetic Testing Features
Figure 4. Minor Mental State Examination (Mmse) Features
Figure 5. Brain Imaging Features
Figure 6. Global Alzheimer's Disease Diagnostic Market Share by Application in 2021 & 2028
Figure 7. Early-Onset Alzheimer's Disease Case Studies
Figure 8. Familial Alzheimer's Disease Case Studies
Figure 9. Late-Onset Alzheimer's Disease Case Studies
Figure 10. Alzheimer's Disease Diagnostic Report Years Considered
Figure 11. Global Alzheimer's Disease Diagnostic Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Alzheimer's Disease Diagnostic Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Alzheimer's Disease Diagnostic Market Share by Region: 2021 VS 2028
Figure 14. Global Alzheimer's Disease Diagnostic Market Share by Players in 2021
Figure 15. Global Top Alzheimer's Disease Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Diagnostic as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Alzheimer's Disease Diagnostic Revenue in 2021
Figure 17. North America Alzheimer's Disease Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Alzheimer's Disease Diagnostic Market Share by Country (2017-2028)
Figure 19. United States Alzheimer's Disease Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Alzheimer's Disease Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Alzheimer's Disease Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Alzheimer's Disease Diagnostic Market Share by Country (2017-2028)
Figure 23. Germany Alzheimer's Disease Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Alzheimer's Disease Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Alzheimer's Disease Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Alzheimer's Disease Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Alzheimer's Disease Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Alzheimer's Disease Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Alzheimer's Disease Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Alzheimer's Disease Diagnostic Market Share by Region (2017-2028)
Figure 31. China Alzheimer's Disease Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Alzheimer's Disease Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Alzheimer's Disease Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Alzheimer's Disease Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Alzheimer's Disease Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Alzheimer's Disease Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Alzheimer's Disease Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Alzheimer's Disease Diagnostic Market Share by Country (2017-2028)
Figure 39. Mexico Alzheimer's Disease Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Alzheimer's Disease Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Alzheimer's Disease Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Alzheimer's Disease Diagnostic Market Share by Country (2017-2028)
Figure 43. Turkey Alzheimer's Disease Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Alzheimer's Disease Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Eli Lilly and Company Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2017-2022)
Figure 46. Novartis Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2017-2022)
Figure 47. Merck Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2017-2022)
Figure 48. F. Hoffmann-La Roche Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2017-2022)
Figure 49. Pfizer Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2017-2022)
Figure 50. TauRx Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2017-2022)
Figure 51. Alector Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2017-2022)
Figure 52. Accera Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2017-2022)
Figure 53. Treventis Corporation Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2017-2022)
Figure 54. Neuro-Bio Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2017-2022)
Figure 55. Cognition Therapeutics Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2017-2022)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed